In Austria, Industry Worries Over Loss Of EU Medtech NBs
Executive Summary
EU member state Austria has lost its only two medtech notified bodies, which is ringing alarm bells for local medtech industry advocates who fear there will be a loss of momentum and profile for the national medtech ecosystem.
You may also be interested in...
Exec: EU May Lose Out On More Innovation As MDR Pressure On NBs Begins To Bite
The new MDR and IVDR were drafted with highest interests of EU patients in mind, but they may yet have a devastating effect on the EU's speedy access to innovation in general, and on medtech SMEs in particular. That is the view of one Swiss medtech CEO; he also has grave concerns about the loss of EU notified bodies and the impact on manufacturers.
19 Countries Have Submitted Bids To Host The EMA Post-Brexit
Formal offers to host the European Medicines Agency were received from 19 countries by the deadline of July 31. The European Commission will now begin assessing the bids on the basis of six criteria, with a final decision expected in November.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.